» Articles » PMID: 20194130

A Mutation of the Epithelial Sodium Channel Associated with Atypical Cystic Fibrosis Increases Channel Open Probability and Reduces Na+ Self Inhibition

Overview
Journal J Physiol
Specialty Physiology
Date 2010 Mar 3
PMID 20194130
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Increased activity of the epithelial sodium channel (ENaC) in the respiratory airways contributes to the pathophysiology of cystic fibrosis (CF), a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In some patients suffering from atypical CF a mutation can be identified in only one CFTR allele. We recently identified in this group of CF patients a heterozygous mutation (W493R) in the alpha-subunit of ENaC. Here, we investigate the functional effects of this mutation by expressing wild-type alpha beta gamma ENaC or mutant alpha(W493R)beta gamma ENaC in Xenopus oocytes. The alpha W493R mutation stimulated amiloride-sensitive whole-cell currents (Delta I(ami)) by approximately 4-fold without altering the single-channel conductance or surface expression of ENaC. As these data suggest that the open probability (P(o)) of the mutant channel is increased, we investigated the proteolytic activation of ENaC by chymotrypsin. Single-channel recordings revealed that chymotrypsin activated near-silent channels in outside-out membrane patches from oocytes expressing wild-type ENaC, but not in membrane patches from oocytes expressing the mutant channel. In addition, the alpha W493R mutation abolished Na(+) self inhibition of ENaC, which might also contribute to its gain-of-function effects. We conclude that the alpha W493R mutation promotes constitutive activation of ENaC by reducing the inhibitory effect of extracellular Na(+) and decreasing the pool of near-silent channels. The resulting gain-of-function phenotype of the mutant channel might contribute to the pathophysiology of CF in patients carrying this mutation.

Citing Articles

Epithelial Na Channels Function as Extracellular Sensors.

Kashlan O, Wang X, Sheng S, Kleyman T Compr Physiol. 2024; 14(2):1-41.

PMID: 39109974 PMC: 11309579. DOI: 10.1002/cphy.c230015.


Design and Synthesis of Novel Squaraine-Based Fluorescent Probe for Far-Red Detection of Chymotrypsin Enzyme.

Gupta S, Balyan P, Mavileti S, Pandey S, Kato T Molecules. 2024; 29(6).

PMID: 38542918 PMC: 10975582. DOI: 10.3390/molecules29061282.


Effects of the environment on the evolution of the vertebrate urinary tract.

V Wiener S Nat Rev Urol. 2023; 20(12):719-738.

PMID: 37443264 DOI: 10.1038/s41585-023-00794-3.


The Epithelial Sodium Channel-An Underestimated Drug Target.

Lemmens-Gruber R, Tzotzos S Int J Mol Sci. 2023; 24(9).

PMID: 37175488 PMC: 10178586. DOI: 10.3390/ijms24097775.


Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.

Salinas D, Wee C, Bailey B, Raraigh K, Conrad D Ann Am Thorac Soc. 2022; 20(4):523-531.

PMID: 36409994 PMC: 10112408. DOI: 10.1513/AnnalsATS.202201-024OC.


References
1.
Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

2.
Wielputz M, Lee I, Dinudom A, Boulkroun S, Farman N, Cook D . (NDRG2) stimulates amiloride-sensitive Na+ currents in Xenopus laevis oocytes and fisher rat thyroid cells. J Biol Chem. 2007; 282(38):28264-73. DOI: 10.1074/jbc.M702168200. View

3.
Garty H, Palmer L . Epithelial sodium channels: function, structure, and regulation. Physiol Rev. 1997; 77(2):359-96. DOI: 10.1152/physrev.1997.77.2.359. View

4.
Hummler E, Barker P, GATZY J, Beermann F, Verdumo C, Schmidt A . Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet. 1996; 12(3):325-8. DOI: 10.1038/ng0396-325. View

5.
Kraus C, Reis A, Naehrlich L, Dotsch J, Korbmacher C, Rauh R . Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis. Cell Physiol Biochem. 2007; 19(5-6):239-48. DOI: 10.1159/000100643. View